TD Asset Management
APLS icon

TD Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-38,692
Closed -$1.23M 1218
2024
Q4
$1.23M Sell
38,692
-199,520
-84% -$6.37M ﹤0.01% 1088
2024
Q3
$7.02M Sell
238,212
-73,620
-24% -$2.17M 0.01% 713
2024
Q2
$12M Sell
311,832
-147,570
-32% -$5.66M 0.01% 592
2024
Q1
$27M Sell
459,402
-23,920
-5% -$1.41M 0.03% 418
2023
Q4
$28.9M Buy
483,322
+112,465
+30% +$6.73M 0.03% 388
2023
Q3
$14.1M Sell
370,857
-107,869
-23% -$4.1M 0.02% 508
2023
Q2
$43.6M Buy
478,726
+100,758
+27% +$9.18M 0.05% 293
2023
Q1
$24.9M Buy
377,968
+106,348
+39% +$7.01M 0.03% 402
2022
Q4
$14M Sell
271,620
-7,096
-3% -$367K 0.02% 518
2022
Q3
$18.2M Buy
278,716
+4
+0% +$262 0.02% 431
2022
Q2
$12.6M Buy
278,712
+31,026
+13% +$1.4M 0.01% 546
2022
Q1
$12.6M Buy
247,686
+86,641
+54% +$4.4M 0.01% 597
2021
Q4
$7.61M Buy
161,045
+41,381
+35% +$1.96M 0.01% 748
2021
Q3
$3.94M Sell
119,664
-19,738
-14% -$651K ﹤0.01% 886
2021
Q2
$8.92M Buy
139,402
+36,779
+36% +$2.35M 0.01% 681
2021
Q1
$4.4M Buy
102,623
+26,180
+34% +$1.12M ﹤0.01% 864
2020
Q4
$4.37M Buy
76,443
+9,700
+15% +$555K 0.01% 827
2020
Q3
$2.01M Hold
66,743
﹤0.01% 905
2020
Q2
$2.18M Buy
66,743
+35,500
+114% +$1.16M ﹤0.01% 858
2020
Q1
$837K Buy
31,243
+8,478
+37% +$227K ﹤0.01% 1045
2019
Q4
$697K Hold
22,765
﹤0.01% 1184
2019
Q3
$548K Buy
22,765
+5,824
+34% +$140K ﹤0.01% 1159
2019
Q2
$429K Hold
16,941
﹤0.01% 1207
2019
Q1
$330K Sell
16,941
-2,900
-15% -$56.5K ﹤0.01% 1247
2018
Q4
$262K Buy
19,841
+400
+2% +$5.28K ﹤0.01% 1323
2018
Q3
$346K Hold
19,441
﹤0.01% 1353
2018
Q2
$428K Buy
+19,441
New +$428K ﹤0.01% 1292